PRESENTED BY MEDVICA INT’L

“The electric thimble that detects signs of heart disease”

Ron Lazzarini – 970.227.1314 – rlazzarini@medvica.com

WHAT IS IT? FDA approved, CE-marked, and validated by nearly

100 papers in peer-reviewed journals This device non-invasively measures endothelial

function Endothelial dysfunction is defined as either

decreased bioavailability of nitric oxide (which is integral to endothelial health), or as an impairment of endothelium-dependent vasodilation

Systemic manifestations of endothelial dysfunction include: stroke/TIA’s, sudden death from myocardial infarction, renal failure, sleep apnea, erectile dysfunction, metabolic syndrome, claudication, and gangrene.

HOW DOES IT WORK? Fingertip probes measure endothelial

function Device software automatically records and

analyzes test results 15 minute test can be given by a tech

while the patient waits for the doctor

TEST EXAMPLE

WHAT ARE THE BENEFITS? CPT coded (93923) for simple billing and minimal conflict

with insurance companies Increases office revenue while simultaneously

increasing the patients’ quality of care and quality of life Provides incremental data to better predict and treat

patients at risk for CVD, patients who would otherwise go undetected.

More effectively monitor treatment for better patient outcomes.

Measures earliest signs of atherosclerosis, while it is still reversible

Monitors effectiveness of patients being treated for cardiac disease

WHO IS IT FOR? Patients who have one or more cardiac risk

factors Patients on medications – looking for

response and non responders Family members of patients diagnosed with

CAD

WHAT’S THE POINT? Improved quality of patient care. Better patient monitoring means improved

cardiac health and fewer cardiac events. Reduce healthcare costs. $28.6B per year is

spent on treating patients with congestive heart failure. EndoPAT detects cardiac risk while it is still reversible.

Increase revenue for doctors. Private insurers reimburse up to $500 per test, adding to the bottom-line of the doctor’s office.

HOW MUCH DOES IT COST?Item P/N Quantity Description Unit

Price $001 FG1600014 1 ENDO-PAT2000 Kit:

Endo-PAT2000 deviceCD SW,Set of 30 AnchorsAdditional New Application: Augmentation Index

$29,500

002 AC0001600 1 Accessory package (arm-support, cuff)

$450

003 AC1600004 1 12 Pneumatic Endo Probes $240004 AC1680030 1 Laptop for ED2000 $2,000005 EPI Extended Service Plan

Warranty$2,000

IRS Section 179 allows businesses to immediately expense the first $250,000 of capital equipment

purchased each year against current year net income.

RETURN ON INVESTMENT

A unique, office-based, vascular health diagnostic tool at a very affordable price.

No money down and deferred payment options Monthly payments of approx $600-700 Four 20-minute endoPAT studies/month =

breakeven One study per day, profit is approx $3,300/month Five studies per day, profit is approx

$16,500/month 25 studies per day, profit is approx

$82,500/month

WHY SHOULD I (THE DOCTOR) USE IT?

Diagnose patients who have low CRFs Monitor drug response Reimbursed by insurance New revenue stream

CONCLUSIONS

EndoPAT 2000 provides incremental data to better predict and treat patients at risk for Cardio-Vascular Disease, patients who would otherwise go undetected.

EndoPAT studies tell you if treatment is effective.

Improved patient monitoring and early detection means increased patient compliance with pharmaceutical treatment and lifestyle recommendations.

Available and simple financing High Return on Investment

ENDOPAT2000 IN THE NEWS

Fox News Clip